News Focus
News Focus
Followers 616
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: sox040713 post# 78376

Saturday, 11/15/2014 5:42:21 PM

Saturday, November 15, 2014 5:42:21 PM

Post# of 405212
Agreed... that's why the science progression is my primary concern along with being kept up to date.

http://clinicaltrials.gov/ct2/results?term=cellceutix

http://cellceutix.com/category/press-release/#sthash.sOGrM5ZC.dpbs





In Reply to 'sox040713'
I think an impressive bottom-line data will push the SP to the $4-$5 range, but only short term catalyst is the partnership/license deal that can significantly increase the SP. Only Leo knows whether a deal is in the works. Uplisting may increase the SP temporarily, but the gain will not last if the science does not progress.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y